Showing results (41-50 of 190) with videos related to
Sort By:
Pageof 19
British Journal of Haematology|November 7, 2022
Higher than normal mitochondrial DNA content associated with better outcome in acute promyelocytic leukaemia? MaybePeter H WiernikCurrent Treatment Options in Oncology|May 6, 2014
Optimal therapy for adult patients with acute myeloid leukemia in first complete remissionPeter H WiernikCurrent Treatment Options in Oncology|April 30, 2004
Second neoplasms in patients with chronic lymphocytic leukemiaPeter H WiernikClinical Advances in Hematology & Oncology : H&O|July 26, 2008
Serum CA125 and PSA concentrations in patients with lymphomaPeter H WiernikClinical Advances in Hematology & Oncology : H&O|August 25, 2010
FLT3 inhibitors for the treatment of acute myeloid leukemiaPeter H WiernikCurrent Treatment Options in Oncology|November 20, 2008
Treatment of hematologic neoplasms with new immunomodulatory drugs (IMiDs)Peter H WiernikCurrent Treatment Options in Oncology|September 30, 2011
Acute lymphoblastic leukemia of adulthood: progress or not?Peter H WiernikOncology (Williston Park, N.Y.)|December 10, 2002
Managing toxicities of high-dose interleukin-2Rowena N Schwartz, Lori Stover, Janice P DutcherCancer|July 2, 2003
Phase II study of alpha2 interferon in the treatment of the chronic myeloproliferative disorders (E5487): a trial of the Eastern Cooperative Oncology GroupArthur I Radin, Haesook T Kim, Barbara W Grant, et al.Oncology (Williston Park, N.Y.)|August 9, 2012
Integrating innovative therapeutic strategies into the management of renal cell carcinomaJanice P Dutcher, Waleed Fouad Mourad, Ronald D EnnisPageof 19